Tectonic Therapeutic (TECX) Return on Capital Employed (2018 - 2026)
Tectonic Therapeutic (TECX) reported Return on Capital Employed of 38.63% for Q1 2026, down 988.0% year-over-year from 4.35% in Q1 2025, and down 19.22% quarter-over-quarter from 32.4% in Q4 2025.
Tectonic Therapeutic (TECX) Return on Capital Employed (2018 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 9 years of Return on Capital Employed data on file, last reported at 38.63% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 38.63%, down 988.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 38.63% (down 988.0% YoY), and the FY2025 annual result was 42.59%, up 2603.0% from the prior year.
- Return on Capital Employed slipped to 38.63% in Q1 2026 per TECX's latest filing, from 32.4% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 25.28% in Q2 2025 and troughed at 162.42% in Q4 2023.
- A 5-year average of 65.33% and a median of 62.14% in 2023 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2023 and 2024: Return on Capital Employed plunged 6065 bps in 2023, then jumped 12353 bps in 2024.
- A 5-year view of Return on Capital Employed shows it stood at 101.76% in 2022, then plunged by 60 bps to 162.42% in 2023, then soared by 76 bps to 38.89% in 2024, then rose by 17 bps to 32.4% in 2025, then retreated by 19 bps to 38.63% in 2026.
- Business Quant data shows TECX's Return on Capital Employed at 38.63% in Q1 2026, 32.4% in Q4 2025, and 27.64% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 450.31% |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 51.73% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -107.40% |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -50.43% |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - | -38.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.63% |
| Dec 31, 2025 | -32.40% |
| Sep 30, 2025 | -27.64% |
| Jun 30, 2025 | -25.28% |
| Mar 31, 2025 | -28.75% |
| Dec 31, 2024 | -38.89% |
| Sep 30, 2024 | -32.56% |
| Jun 30, 2024 | -37.46% |
| Mar 31, 2024 | -69.09% |
| Dec 31, 2023 | -162.42% |
| Sep 30, 2023 | -62.14% |
| Jun 30, 2023 | -86.91% |
| Mar 31, 2023 | -127.86% |
| Dec 31, 2022 | -101.76% |
| Sep 30, 2022 | -88.87% |
| Jun 30, 2022 | -79.57% |
| Mar 31, 2022 | -70.38% |
| Dec 31, 2021 | -62.30% |
| Sep 30, 2021 | -58.17% |
| Jun 30, 2021 | -54.67% |